CNIPA Deputy Commissioner Meets with Vice President of INTERPAT in Beijing

Recently, Hu Wenhui, Deputy Commissioner of the China National Intellectual Property Administration (CNIPA), met in Beijing with John Conway, Vice President of INTERPAT, and representatives of its member companies.

Hu stated that China attaches great importance to intellectual property (IP) protection. Sound IP protection is an integral part of a first-class business environment that is market-oriented, law-based, and internationalized. The CNIPA is willing to maintain close communication with the industry, actively listen to the opinions and suggestions of companies from various countries on IP development in China, respond promptly to their IP protection concerns, and provide necessary assistance.

Conway noted that China is an important market in the global pharmaceutical industry. In recent years, the CNIPA has made positive progress in strengthening pharmaceutical IP protection, which has further enhanced the confidence of multinational pharmaceutical companies in their development in China.

The two sides also exchanged views on issues including the early resolution mechanism for drug patent disputes, supplementary submission of experimental data for drug patents, and the patent term extension system.(Source from CNIPA Website)